The main office of represented VC is situated in the New York. The venture was found in North America in United States.
For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. The fund has exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. We can highlight the next thriving fund investment areas, such as Medical, Telecommunications. Among the most popular portfolio startups of the fund, we may highlight Auxilium Pharmaceuticals, Relypsa, Sirna Therapeutics.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Sprout Group, startups are often financed by Kleiner Perkins, Norwest Venture Partners, Jerusalem Venture Partners (JVP). The meaningful sponsors for the fund in investment in the same round are Delphi Ventures, Enterprise Partners, Norwest Venture Partners. In the next rounds fund is usually obtained by Delphi Ventures, Three Arch Partners, Kleiner Perkins.
Besides them, we counted 2 critical employees of this fund in our database.
Considering the real fund results, this VC is 14 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. Opposing the other organizations, this Sprout Group works on 2 percentage points more the average amount of lead investments. The fund is constantly included in 2-6 investment rounds annually. The increased amount of exits for fund were in 2004. The average startup value when the investment from Sprout Group is 50-100 millions dollars. The top activity for fund was in 2000.
Related Funds
Funds with similar focus
Fund Name | Location |
Alkermes | County Dublin, Dublin, Ireland |
Apex Capital | New York, New York, United States |
Capital One | Illinois, United States, Virginia |
Cariden Technologies | California, Sunnyvale, United States |
ChaoShan Ziben | - |
Concentric Equity Partners | Chicago, Illinois, United States |
Finpiemonte | - |
Ipsen | Boulogne-Billancourt, France, Ile-de-France |
Korea Asset Investment Securities | - |
Prudence Investment Management | China, Hong Kong, Hong Kong Island |
Quadia | Geneva, Geneve, Switzerland |
Roynat Equity Partners | Alberta, Calgary, Canada |
Samena Capital | England, London, United Kingdom |
SQM Frontier Management | Arlington, United States, Virginia |
SU&Partners | Seocho, Seoul-t'ukpyolsi, South Korea |
TAKKT AG | Baden-Wurttemberg, Germany, Stuttgart |
Thynk Ventures | - |
Tsing Capital | Beijing, Beijing, China |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
CallFixie | $2M | 31 Mar 2016 | Haryana | ||
Relypsa | $80M | 14 Aug 2012 | Redwood City, California, United States | ||
Relypsa | $70M | 08 Aug 2011 | Redwood City, California, United States | ||
Relypsa | $70M | 13 Sep 2010 | Redwood City, California, United States | ||
Labcyte | $3M | 26 Mar 2008 | San Jose, California, United States | ||
Relypsa | $33M | 29 Oct 2007 | Redwood City, California, United States | ||
TradeBeam | $29M | 23 Aug 2007 | California, United States | ||
NeuroVista | $33M | 11 May 2007 | Seattle, Washington, United States | ||
Kalypsys | $100M | 29 Nov 2006 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
CallFixie | $2M | 31 Mar 2016 | Haryana | ||
Relypsa | $80M | 14 Aug 2012 | Redwood City, California, United States | ||
Relypsa | $70M | 08 Aug 2011 | Redwood City, California, United States | ||
Relypsa | $70M | 13 Sep 2010 | Redwood City, California, United States | ||
Labcyte | $3M | 26 Mar 2008 | San Jose, California, United States | ||
Relypsa | $33M | 29 Oct 2007 | Redwood City, California, United States | ||
TradeBeam | $29M | 23 Aug 2007 | California, United States | ||
NeuroVista | $33M | 11 May 2007 | Seattle, Washington, United States | ||
Kalypsys | $100M | 29 Nov 2006 | San Diego, California, United States |